Join Ziccum at RNA Leaders USA Congress on September 4 – 5, 2024, in San Diego, USA and attend our presentation on September 4, 2024, at 16.00 covering the topic: “Enabling the Full Potential of mRNA – with Robust, Particle Engineered, Thermostable Dry Product Forms.”
The presentation will be part of the mRNA Therapeutics & Vaccines: Innovating mRNA Modalities track and will highlight how the disruptive technology LaminarPace formulates and dries the most fragile mRNA/LNP compositions and turns them into robust, thermostable dry powder forms. It will also demonstrate the preserved or even increased mRNA activity of LaminarPace dried materials and how this technology substantially lowers costs, enables new treatments, and allows for particle engineering perfectly suitable for inhalable mRNA – which is unique.
Meet Ziccum CEO Ann Gidner and Scientific Director Fabrice Rose at the event. Book a meeting to learn more about LaminarPace and discover the company’s excellent new mRNA/LNP results here: Contact us – Ziccum